Home/Filings/4/0001140361-09-003871
4//SEC Filing

SIGMA TAU FINANZIARIA SPA 4

Accession 0001140361-09-003871

CIK 0000812796other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 12:20 PM ET

Size

41.2 KB

Accession

0001140361-09-003871

Insider Transaction Report

Form 4
Period: 2009-02-11
Transactions
  • Purchase

    Common Stock

    2009-02-11$0.18/sh+25,000,000$4,500,00041,666,667 total(indirect: Indirect)
Transactions
  • Purchase

    Common Stock

    2009-02-11$0.18/sh+25,000,000$4,500,00041,666,667 total(indirect: Indirect)
Transactions
  • Purchase

    Common Stock

    2009-02-11$0.18/sh+25,000,000$4,500,00041,666,667 total(indirect: Indirect)
Transactions
  • Purchase

    Common Stock

    2009-02-11$0.18/sh+25,000,000$4,500,00041,666,667 total(indirect: Indirect)
Footnotes (1)
  • [F1]Shares directly owned by Sigma-Tau Pharmaceuticals, Inc. (?Pharmaceuticals?). Pharmaceuticals is a direct wholly-owned subsidiary of Sigma-Tau America S.A. (?America?). America is a direct wholly-owned subsidiary of Sigma-Tau International S.A. (?International?). International is a direct wholly-owned subsidiary of Sigma-Tau Finanziaria S.p.A.

Issuer

DOR BIOPHARMA INC

CIK 0000812796

Entity typeother

Related Parties

1
  • filerCIK 0001092601

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 12:20 PM ET
Size
41.2 KB